
USA - New York Stock Exchange - NYSE:APHA -
The current stock price of APHA is 15.38 null. In the past month the price decreased by -15.12%. In the past year, price increased by 353.69%.
Aphria Inc. produces, supplies and sells medical cannabis primarily in Canada. The company offers sativa, indica and hybrid medical marijuana products, as well as cannabis oils. Aphria Inc. is headquartered in Leamington, Canada.
Aphria Inc
98 TALBOT STREET W.
LEAMINGTON A6 N8H 1M8
CEO: Irwin Simon
Aphria Inc. produces, supplies and sells medical cannabis primarily in Canada. The company offers sativa, indica and hybrid medical marijuana products, as well as cannabis oils. Aphria Inc. is headquartered in Leamington, Canada.
The current stock price of APHA is 15.38 null. The price decreased by -0.45% in the last trading session.
APHA does not pay a dividend.
APHA has a ChartMill Technical rating of 5 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
Aphria Inc (APHA) will report earnings on 2022-02-08, before the market open.
ChartMill assigns a technical rating of 5 / 10 to APHA. When comparing the yearly performance of all stocks, APHA is one of the better performing stocks in the market, outperforming 96.64% of all stocks.
ChartMill assigns a fundamental rating of 3 / 10 to APHA. APHA may be in some trouble as it scores bad on both profitability and health.
Over the last trailing twelve months APHA reported a non-GAAP Earnings per Share(EPS) of -0.35. The EPS increased by 45.45% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -98.29% | ||
| ROA | -20.56% | ||
| ROE | N/A | ||
| Debt/Equity | 0.15 |